NRC Health Goodwill, Gross
NRC Health (NRC) had Goodwill, Gross of $66.87 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillGross · last filed 2026-03-05
- 2025-06-30: Goodwill, Gross $66.87M.
- 2025-03-31: Goodwill, Gross $66.87M.
- 2024-12-31: Goodwill, Gross $66.87M.
- 2024-09-30: Goodwill, Gross $66.92M.
| Period end | Goodwill, Gross |
|---|---|
| 2025-06-30 | $66.87M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $66.87M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $66.87M 10-K · filed 2026-03-05 |
| 2024-09-30 | $66.92M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $62.33M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $62.33M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $62.33M 10-K · filed 2026-03-05 |
| 2023-09-30 | $62.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $62.33M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $62.33M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $62.33M 10-K · filed 2024-02-27 |
| 2022-09-30 | $62.33M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $62.33M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $62.33M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $62.33M 10-K · filed 2023-03-03 |
| 2021-09-30 | $62.33M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $62.35M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $62.33M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $57.97M 10-K · filed 2022-03-04 |
| 2019-12-31 | $57.94M 10-K · filed 2021-03-05 |
| 2013-12-31 | $57.59M 10-K · filed 2014-03-04 |
| 2012-12-31 | $57.80M 10-K · filed 2014-03-04 |
| 2011-12-31 | $57.73M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |